Nicholson John 4
4 · NEKTAR THERAPEUTICS · Filed Mar 8, 2018
Insider Transaction Report
Form 4
Nicholson John
SVP & Chief Financial Officer
Transactions
- Sale
Common Stock
2018-03-06$98.29/sh−120,000$11,794,800→ 267,657 total - Sale
Common Stock
2018-03-07$100.45/sh−100,144$10,059,465→ 167,513 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $98.00 to $100.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- [F2]This transaction was executed in multiple trades at prices ranging from $99.00 to $101.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.